Lisa Dalton
No más puestos en curso
Fortuna: 517 $ al 31/07/2023
Perfil
Lisa Dalton served as the Head of Human Resources at Spark Therapeutics, Inc. from 2014 to 2019.
Prior to that, she was the Vice President of Human Resources at Shire Pharmaceuticals, Inc. She also served as an Independent Director at Nabriva Therapeutics Plc from 2021 to 2023.
Dalton received an undergraduate degree from The Pennsylvania State University and an MBA from Rutgers Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NABRIVA THERAPEUTICS PLC
0.01% | 31/01/2023 | 364 ( 0.01% ) | 517 $ | 31/07/2023 |
Antiguos cargos conocidos de Lisa Dalton.
| Empresas | Cargo | Fin |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Director/Board Member | 30/07/2023 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Human Resources Officer | - |
| SPARK THERAPEUTICS, INC. | Human Resources Officer | - |
Formación de Lisa Dalton.
| The Pennsylvania State University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Lisa Dalton
